FDA, Device Industry Chiefs Converge On TPLC Approach To Tech Assessment

CDRH's total product life cycle model has the potential to allay industry concerns about the role of health technology assessment for "breakthrough" devices, center director David Feigal suggested June 6.

More from Archive

More from Medtech Insight